首页 | 本学科首页   官方微博 | 高级检索  
     


Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy
Authors:Zeng Zhang  Jin-Wei He  Wen-Zhen Fu  Chang-Qing Zhang  Zhen-Lin Zhang
Affiliation:1. Metabolic Bone Disease and Genetic Research Unit, Department of Osteoporosis and Bone Diseases, Shanghai Jiao Tong University Affiliated the Sixth People''s Hospital, Shanghai 200233, 600 Yi-Shan Rd., PR China;2. Department of Orthopedic Surgery, Shanghai Jiao Tong University Affiliated the Sixth People''s Hospital, Shanghai 200233, 600 Yi-Shan Rd., PR China
Abstract:Primary hypertrophic osteoarthropathy (PHO) is a rare monogenetic disease characterized by digital clubbing, periostosis and pachydermia. Mutations in the 15-hydroxy-prostaglandin dehydrogenase (HPGD) gene and solute carrier organic anion transporter family member 2A1 (SLCO2A1) gene have been shown to be associated with PHO. Here, we described clinical characteristics in a Chinese patient with PHO, and identified two novel mutations in SLCO2A1: a heterozygous guanine-to-thymidine transition at the invariant − 1 position of the acceptor site of intron 2 (c.235-1G > T) and a heterozygous missense mutation p.Pro219Leu (c.656C > T) in exon 5.
Keywords:HGMD, Human Gene Mutation Database   HPGD, Hydroxyprostaglandin dehydrogenase 15-(NAD)   PCR, Polymerase chain reaction   PGE2, Prostaglandin E2   PGE-M, Prostaglandin E metabolite   PGT, Prostaglandin transporter   PHO, Primary hypertrophic osteoarthropathy   PHOAR1, Primary hypertrophic osteoathropathy autosomal recessive 1   PHOAR2, Primary hypertrophic osteoathropathy autosomal recessive 2   SLCO2A1, Solute carrier organic anion transporter family, member 2A1
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号